Largest health care biotech companies by total liabilities
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Amgen leads the 24 health care biotech companies ranked by total liabilities, at SGD 105.8B, ahead of Gilead Sciences (SGD 47B) and Biogen (SGD 14.4B). Figures as of 19 Nov 2026, 21:04 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 24
- First
- AmgenSGD 105.8B
- Median
- SGD 908.4M
- Combined market value
- SGD 1.07T
- Countries
- 5
Market values as of .
All countries▾
Health Care▾
Biotech▾
| # | Company | Total liabilities ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AmgenAMGN · Health Care | SGD 105.8B | SGD 306.6B | SGD 566.91 | 1.14% down | 32% up | ||
| 2 | Gilead SciencesGILD · Health Care | SGD 47B | SGD 266.8B | SGD 215.14 | 1.45% down | 35% up | ||
| 3 | BiogenBIIB · Health Care | SGD 14.4B | SGD 47.2B | SGD 319.27 | 1.70% down | 49% up | ||
| 4 | ModernaMRNA · Health Care | SGD 4.8B | SGD 104.2B | SGD 257.51 | 1.29% up | 780% up | ||
| 5 | BioNTechBNTX · Health Care | SGD 4B | SGD 26.1B | SGD 105.13 | 2.26% down | 14% down | ||
| 6 | QiagenQGEN · Health Care | SGD 3.2B | SGD 13.2B | SGD 64.10 | 0.12% up | 9% up | ||
| 7 | Halozyme TherapeuticsHALO · Health Care | SGD 3.2B | SGD 13.7B | SGD 120.20 | 2.88% down | 39% up | ||
| 8 | Neurocrine BiosciencesNBIX · Health Care | SGD 1.8B | SGD 20.5B | SGD 202.30 | 3.85% down | 17% up | ||
| 9 | argenxARGX · Health Care | SGD 1.8B | SGD 76.5B | SGD 1,217.02 | 0.08% up | 2% up | ||
| 10 | ImmunityBioIBRX · Health Care | SGD 1.3B | SGD 9B | SGD 8.49 | 1.94% down | 232% up | ||
| 11 | RepligenRGEN · Health Care | SGD 1.1B | SGD 14.1B | SGD 220.00 | 1.38% down | 12% up | ||
| 12 | Revolution MedicinesRVMD · Health Care | SGD 934.3M | SGD 44.5B | SGD 205.97 | 0.24% down | 129% up | ||
| 13 | ExelixisEXEL · Health Care | SGD 882.5M | SGD 20.8B | SGD 85.05 | 3.60% down | 63% up | ||
| 14 | Bio-TechneTECH · Health Care | SGD 618.2M | SGD 14.8B | SGD 93.92 | 0.07% down | 24% up | ||
| 15 | CRISPR TherapeuticsCRSP · Health Care | SGD 443.7M | SGD 4.9B | SGD 50.29 | 3.14% down | 18% down | ||
| 16 | VaxcytePCVX · Health Care | SGD 409.8M | SGD 11.9B | SGD 75.40 | 0.27% down | 23% up | ||
| 17 | Adaptive BiotechnologiesADPT · Health Care | SGD 371.7M | SGD 5.9B | SGD 36.24 | 1.44% down | 74% up | ||
| 18 | Kodiak SciencesKOD · Health Care | SGD 250.8M | SGD 8.3B | SGD 126.48 | 0.09% up | 399% up | ||
| 19 | Twist BioscienceTWST · Health Care | SGD 218.2M | SGD 9.8B | SGD 144.20 | 4.07% down | 346% up | ||
| 20 | Kymera TherapeuticsKYMR · Health Care | SGD 210.8M | SGD 13.2B | SGD 154.24 | 1.44% down | 87% up | ||
| 21 | Scholar Rock HoldingSRRK · Health Care | SGD 205.1M | SGD 7.9B | SGD 65.07 | 4.94% up | 26% up | ||
| 22 | Krystal BiotechKRYS · Health Care | SGD 147.6M | SGD 12.1B | SGD 408.01 | 0.15% up | 54% up | ||
| 23 | ImmunovantIMVT · Health Care | SGD 134.9M | SGD 8.7B | SGD 42.01 | 1.96% down | 46% up | ||
| 24 | CG OncologyCGON · Health Care | SGD 50.4M | SGD 9.5B | SGD 105.81 | 2.38% up | 97% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total liabilities is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Where a company reports no total-liabilities line, it is worked out as assets less equity. Sums are converted from US dollars at today's exchange rate (1 USD = 1.2919 SGD).
Questions and answers
Which health care biotech companies rank first by total liabilities?
Amgen (SGD 105.8B), Gilead Sciences (SGD 47B) and Biogen (SGD 14.4B) are the top three of the 24 health care biotech companies ranked by total liabilities as of 19 Nov 2026, 21:04 UTC.
How many health care biotech companies are in this ranking?
24 are ranked by total liabilities.
What are these health care biotech companies worth together?
The 24 health care biotech companies ranked by total liabilities have a combined market value of SGD 1.07T as of 19 Nov 2026, 21:04 UTC.
What does ranking by total liabilities measure?
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest health care biotech companies by total liabilities”, data as of 19 November 2026. https://funkfolio.com/companies/category/biotech?sector=health-care&by=total-liabilities
Underlying data: Yahoo Finance; SEC EDGAR.